LAB FUNDING 

Our work and lab members are currently funded by:

• Parkinson's UK
• The Medical Research Council
• The Biotechnology and Biological Sciences Resarch Council
• National Science Foundation USA
  
• The University of Oxford Clarendon Fund

My laboratory focuses on understanding dopamine neurotransmission in the brain, particularly in the basal ganglia. We seek to improve understanding of underlying mechanisms, their regulation, and dysfunction in neurodegenerative and other neurological disorders, particularly Parkinson's disease, and addiction, as well as to gain insights for novel therapeutic avenues. We are a founding group of the Oxford Parkinson's Disease Centre (OPDC).

I studied Natural Sciences at the University of Cambridge, and undertook my DPhil at the University of Oxford Department of Pharmacology as a Mary Goodger Scholar. I held Junior Research Fellowships from Oxford and a Beit Memorial Fellowship, based at the University Department of Pharmacology, Oxford, with stints at New York University Departments of Physiology and Biophysics, and Neurosurgery, and the University of North Carolina Department of Chemistry. I joined the Department of Physiology, Anatomy and Genetics in 2006 as University Lecturer and Tutor for Medicine at Christ Church. I became Professor of Neuroscience in 2014.

I am a Theme Co-Director of the OPDC. I am Associate Editor at npj Parkinson's Disease. I serve on the Parkinson's UK College of Experts Panel, on the Editorial Advisory Board for ACS Chemical Neuroscience and on the Scientific Advisory Board for the International Society for Monitoring Molecules in Neuroscience. In 2018, I served as Chair of this Society's 17th International Conference, held in Oxford.

I also serve on the DPAG Athena SWAN committee.

*Group News*

For our news, please see http://www.dpag.ox.ac.uk/research/cragg-group